IL10 and neoplasm: In fact, NT cells treated with IL-10 produced tumor activator factors such as RhoA, the glia maturation factor beta, galectin-1, the isocitrate dehydrogenase subunit alpha, and the D-3-phosphoglycerate dehydrogenase (Figure S2).